Insider Selling: Phreesia, Inc. (NYSE:PHR) CFO Sells 836 Shares of Stock

Phreesia, Inc. (NYSE:PHR) CFO Balaji Gandhi sold 836 shares of the stock in a transaction that occurred on Wednesday, January 15th. The shares were sold at an average price of $26.98, for a total transaction of $22,555.28. Following the transaction, the chief financial officer now owns 147,673 shares in the company, valued at approximately $3,984,217.54. This trade represents a 0.56 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Balaji Gandhi also recently made the following trade(s):

• On Monday, January 6th, Balaji Gandhi sold 3,195 shares of Phreesia stock. The shares were sold at an average price of $26.61, for a total transaction of $85,018.95.

Phreesia Price Performance

Shares of Phreesia stock opened at $27.24 on Monday. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. Phreesia, Inc. has a 52 week low of $17.07 and a 52 week high of $29.16. The stock’s 50-day simple moving average is $23.54 and its 200-day simple moving average is $22.83. The company has a market capitalization of $1.58 billion, a price-to-earnings ratio of -18.53 and a beta of 0.94.

Phreesia (NYSE:PHR) last issued its earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The company had revenue of $106.80 million for the quarter, compared to the consensus estimate of $106.33 million. During the same quarter last year, the company earned ($0.58) EPS. The firm’s quarterly revenue was up 16.6% on a year-over-year basis. As a group, analysts expect that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Phreesia

A number of hedge funds and other institutional investors have recently modified their holdings of PHR. International Assets Investment Management LLC grew its stake in Phreesia by 2,179.7% during the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock valued at $33,000 after acquiring an additional 1,395 shares in the last quarter. Lombard Odier Asset Management USA Corp purchased a new position in shares of Phreesia during the second quarter valued at about $202,000. Point72 DIFC Ltd purchased a new position in shares of Phreesia during the second quarter valued at about $209,000. XTX Topco Ltd bought a new stake in shares of Phreesia in the third quarter worth about $247,000. Finally, Hsbc Holdings PLC purchased a new stake in shares of Phreesia in the second quarter worth about $301,000. Institutional investors own 92.10% of the company’s stock.

Wall Street Analysts Forecast Growth

PHR has been the subject of several research analyst reports. Truist Financial lifted their price objective on Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. Citigroup upped their price target on shares of Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a research report on Friday, January 10th. Royal Bank of Canada raised shares of Phreesia from a “sector perform” rating to an “outperform” rating and raised their price objective for the stock from $24.00 to $32.00 in a report on Wednesday, January 8th. Robert W. Baird reduced their target price on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a report on Wednesday, December 11th. Finally, JMP Securities reiterated a “market outperform” rating and set a $30.00 price target on shares of Phreesia in a research note on Tuesday, December 10th. Twelve investment analysts have rated the stock with a buy rating, According to data from MarketBeat, Phreesia currently has a consensus rating of “Buy” and an average target price of $31.00.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.